Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$353M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$256M |
| 4 |
Alibaba
BABA
|
+$189M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$82M |
| 2 |
Generac Holdings
GNRC
|
+$33.7M |
| 3 |
Pool Corp
POOL
|
+$32.5M |
| 4 |
Keurig Dr Pepper
KDP
|
+$31M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.28% |
| 2 | Consumer Discretionary | 10.77% |
| 3 | Healthcare | 5.09% |
| 4 | Industrials | 4.03% |
| 5 | Financials | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Ecovyst
ECVT
$1.1B
| $312K | ﹤0.01% |
+21,878
| New | +$277K |
|
|
AKU
1527
DELISTED
Akumin Inc
AKU
| $309K | ﹤0.01% |
+102,751
| New | +$345K |
|
|
GAN
1528
DELISTED
GAN Ltd
GAN
| $308K | ﹤0.01% |
+15,202
| New | +$255K |
|
1529
World Kinect Corp
WKC
$1.82B
| $307K | ﹤0.01% |
9,858
-29,709
| -75% | -$793K |
|
1530
Nokia
NOK
$55.6B
| $306K | ﹤0.01% |
+78,235
| New | +$308K |
|
1531
NETGEAR
NTGR
$563M
| $306K | ﹤0.01% |
7,539
-958
| -11% | -$32.6K |
|
1532
Stoke Therapeutics
STOK
$2.09B
| $306K | ﹤0.01% |
+4,944
| New | +$227K |
|
1533
American Tower
AMT
$83.1B
| $305K | ﹤0.01% |
1,358
-8,918
| -87% | -$2.07M |
|
|
YALA
1534
Yalla Group
YALA
$841M
| $305K | ﹤0.01% |
+21,251
| New | +$249K |
|
1535
BILL Holdings
BILL
$4.8B
| $304K | ﹤0.01% |
+2,226
| New | +$263K |
|
|
SAFE
1536
Safehold
SAFE
$1.1B
| $304K | ﹤0.01% |
4,201
+761
| +22% | +$49.6K |
|
|
TRTX
1537
TPG RE Finance Trust
TRTX
$600M
| $304K | ﹤0.01% |
28,656
+17,822
| +165% | +$169K |
|
1538
Ameresco
AMRC
$1.11B
| $303K | ﹤0.01% |
+5,794
| New | +$250K |
|
1539
Heritage Financial
HFWA
$1.19B
| $303K | ﹤0.01% |
+12,938
| New | +$291K |
|
1540
Assurant
AIZ
$14.2B
| $300K | ﹤0.01% |
+2,199
| New | +$285K |
|
|
BDN
1541
Brandywine Realty Trust
BDN
$548M
| $300K | ﹤0.01% |
+25,200
| New | +$271K |
|
1542
The Ensign Group
ENSG
$10.5B
| $300K | ﹤0.01% |
+4,114
| New | +$273K |
|
1543
Evertec
EVTC
$1.77B
| $300K | ﹤0.01% |
+7,635
| New | +$284K |
|
|
FUV
1544
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $299K | ﹤0.01% |
+1,129
| New | +$221K |
|
1545
Greif
GEF
$4.89B
| $297K | ﹤0.01% |
+6,344
| New | +$287K |
|
1546
Orion Group Holdings
ORN
$369M
| $297K | ﹤0.01% |
+59,873
| New | +$232K |
|
1547
America's Car Mart
CRMT
$19.2M
| $296K | ﹤0.01% |
+2,691
| New | +$271K |
|
1548
NMI Holdings
NMIH
$3.42B
| $296K | ﹤0.01% |
+13,052
| New | +$297K |
|
|
SAFE
1549
DELISTED
Safehold Inc.
SAFE
| $296K | ﹤0.01% |
+4,081
| New | +$278K |
|
1550
Community Trust Bancorp
CTBI
$1.39B
| $295K | ﹤0.01% |
+7,960
| New | +$269K |
|
Similar funds
Michael Gelband's Q4 2020 Portfolio in Review
As of Q4 2020, Michael Gelband held 2,600 positions worth $10.3B, up 105% from $5.02B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Michael Gelband deployed $4.62B of net new capital in Q4 2020, opening 918 new positions and adding to 493 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Charles Schwab, an estimated $82M trimmed.
- Michael Gelband's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.
- Michael Gelband added most to Amazon in Q4 2020, an estimated $353M increase.
- Michael Gelband's biggest Q4 2020 reduction was Charles Schwab, cutting an estimated $82M.
- Michael Gelband fully exited Eli Lilly in Q4 2020, selling an estimated $21.7M.
- Michael Gelband's ten largest holdings make up 42% of its $10.3B portfolio in Q4 2020.
- Michael Gelband opened 918 new positions and closed 701 in Q4 2020.
- Michael Gelband's portfolio value rose 105% quarter-over-quarter to $10.3B.
Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.